The company is demonstrably boosted this progress of the new solution for cardiac amyloidosis, employing the investigational drug. Preliminary patient results reveals promising outcomes for patients diagnosed by this https://attrcm481945.topbloghub.com/48728620/bridgebio-advances-cardiac-amyloidosis-therapy-using-attruby